SDGR Stock Analysis — SCHRODINGER INC (Healthcare >> Health Information Services)
SDGR FAQ
What is SDGR's P/E ratio?
SCHRODINGER INC (SDGR) currently trades at a P/E ratio of 35.28.
What is SDGR's ROE?
SCHRODINGER INC reports a Return on Equity (ROE) of -33.00%.
What is SDGR's dividend yield?
SCHRODINGER INC offers a dividend yield of 0.00%.
What is SDGR's Quality Score?
Our AI rates SDGR's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SDGR?
Our AI Timing Score for SDGR is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SDGR belong to?
SCHRODINGER INC is classified under the Healthcare >> Health Information Services sector on the NASDAQ exchange
SDGR AI Analysis Summary
Our AI summary for SDGR: SCHRODINGER INC (NASDAQ), Healthcare >> Health Information Services sector. The stock currently trades at a P/E of 35.28, ROE of -33.00%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 15.14
Price
-0.21
(-1.37%)
Day Change
|
|
|---|
SDGR, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
38% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 15.14 |
| PBV / Sector |
3.66 / 6.33
|
| Earning Per Share | -1.37 |
| PE / Sector |
35.28 / 46.50
|
| PEG or PE/Growth / Sector |
N/A / -0.41
|
| Average 1M Daily Value |
13.89 M
GREAT
|
| Average 1W Daily Value |
11.85 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:27 |
| Symbol | SDGR |
| Name | SCHRODINGER INC |
| Sector | Healthcare >> Health Information Services |
| Market | NASDAQ |
| Listed Shares | 65.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,146.96 / 4,079.00 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1540 Broadway, New York, NY, United States, 10036
Phone: 212 295 5800
Website: https://www.schrodinger.com
Employees: 850
Description: Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Health Information Services
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › Health Information ServicesAnalysed on the same criteria, ordered by market cap
Google